Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Transactions of the Royal Society of Tropical Medicine and Hygiene

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRSTMH.2005.10.008PMID 16443243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection.

  2006cited by this paper
• Natural history of hepatitis C.

  2005cited by this paper
• Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients

  2005cited by this paper
• Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy

  2005cited by this paper
• Answer

  2004cited by this paper
• Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: A collaborative study between Japan, Egypt, and Uzbekistan

  2004cited by this paper
• Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis‐C virus infection in Taiwan: a prospective study

  2003cited by this paper
• Genotyping of hepatitis C virus-comparison of three assays.

  2003cited by this paper
• Influence of Hepatitis C Virus Subtype on Hepatocellular Carcinogenesis: A Multivariate Analysis of a Retrospective Cohort of 593 Patients with Cirrhosis

  2002cited by this paper
• Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C

  2002cited by this paper
• Course and outcome of hepatitis C

  2002cited by this paper
• Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

  2002cited by this paper
• Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis.

  2001cited by this paper
• Serum HCV RNA Levels Correlate with Histological Liver Damage and Concur with Steatosis in Progression of Chronic Hepatitis C

  2001cited by this paper
• Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan

  2001cited by this paper
• Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients

  2000cited by this paper
• Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients

  2000cited by this paper
• Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.

  1999cited by this paper
• Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection

  1999cited by this paper
• Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.

  1999cited by this paper
• Hepatitis c virus genotypes and viremia and hepatocellular carcinoma in the united states

  1999cited by this paper
• HCV genotyping by three methods: analysis of discordant results based on sequencing.

  1999cited by this paper
• A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan.

  1999cited by this paper
• HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

  1998cited by this paper
• HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury

  1998cited by this paper
• Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

  1998cited by this paper
• Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

  1998cited by this paper
• Correlation between virus genotype and chronicity rate in acute hepatitis C.

  1998cited by this paper
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

  1998cited by this paper
• Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan.

  1997cited by this paper
• Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study

  1997cited by this paper
• Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays.

  1997cited by this paper
• Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan

  1997cited by this paper
• Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

  1997cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma.

  1997cited by this paper
• Clinical relevance of hepatitis C virus genotypes.

  1997cited by this paper
• Risk factors of hepatitis C virus infection in a Taiwanese aboriginal community.

  1996cited by this paper
• Serotypes, genotypes and levels of hepatitis C viremia in pregnant women in Taiwan.

  1996cited by this paper
• Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

  1996cited by this paper
• Distribution of Hepatitis C Virus Genotypes Determined by Line Probe Assay in Patients with Chronic Hepatitis C Seen at Tertiary Referral Centers in the United States

  1996cited by this paper
• Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis.

  1996cited by this paper
• Hepatitis C virus genotypes and development of hepatocellular carcinoma

  1995cited by this paper
• Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.

  1995cited by this paper
• Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

  1995cited by this paper
• Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

  1995cited by this paper
• Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C.

  1995cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C.

  1995cited by this paper
• Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.

  1995cited by this paper
• Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C.

  1995cited by this paper
• Laser-solid interaction and dynamics of the laser-ablated materials

  1995cited by this paper
• Genotypes of hepatitis C virus in Taiwan and the progression of liver disease.

  1995cited by this paper
• Genotype distribution of hepatitis C virus infection in Taiwan

  1994cited by this paper
• Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease.

  1994cited by this paper
• Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

  1994cited by this paper
• Genotypes of hepatitis C virus in chronic liver disease in Taiwan

  1994cited by this paper
• Quantification of hepatitis C virus by competitive reverse transcription—polymerase chain reaction: Increase of the virus in advanced liver disease

  1993cited by this paper
• Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

  1993cited by this paper
• Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

  1993cited by this paper
• Viral pathogenesis of hepatocellular carcinoma in the United States

  1993cited by this paper
• Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection

  1991cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

  1990cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

  1989cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper
• Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.

  1971cited by this paper

• Changing epidemiology of hepatitis C virus infection and liver disease mortality in Taiwan.

  2025cites this paper
• Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis

  2023cites this paper
• Genetic history of hepatitis C virus genotype 6 in Taiwan.

  2023cites this paper
• Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C.

  2022cites this paper
• Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy

  2021cites this paper
• Geographic Variation of Indigenous Hepatitis C Virus Subtypes 6g and 6w in an Endemic Area of Southern Taiwan

  2021cites this paper
• The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study.

  2021cites this paper
• Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution

  2021cites this paper
• 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population.

  2020cites this paper
• 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations.

  2020cites this paper
• Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection:a multicenter pooled analysis in Taiwan.

  2020cites this paper
• Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.

  2020cites this paper
• Geographic variation of genotype 6 hepatitis C virus infection in an endemic area of southern Taiwan.

  2020cites this paper
• Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

  2020cites this paper
• High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays.

  2019cites this paper
• Systematic review: epidemiology and response to direct‐acting antiviral therapy in genotype 6 chronic hepatitis C virus infection

  2019cites this paper
• Daclatasvir plus sofosbuvir, with or without ribavirin, is highly effective for all kinds of genotype-2 chronic hepatitis-C infection in Taiwan.

  2019cites this paper
• Treatments of Chronic Hepatitis C Genotype 1b with Oral Paritaprevir/Ritonavir/Ombitasvir+Dasabuvir or Daclatasvir/Asunaprevir: A Real-World Data from Taiwan

  2018cites this paper
• The association of hepatitis C infection with the onset of CKD and progression into ESRD

  2018cites this paper
• Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection

  2018cites this paper
• Epidemiology and Modes of Transmission of HCV in Developing Countries

  2018cites this paper
• Historical epidemiology of hepatitis C virus in select countries—volume 4

  2017cites this paper
• The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance?

  2017cites this paper
• Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype.

  2017cites this paper
• Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study

  2017cites this paper
• High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.

  2017cites this paper
• Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

  2016cites this paper
• Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.

  2016cites this paper
• Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study

  2016cites this paper
• Comparison of the Serum Cholesterol, Insulin Resistance and Markers of Metabolic Syndrome Based on Hepatitis C Virus RNA

  2016cites this paper
• Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3

  2015cites this paper
• Predictors for Early Identification of Hepatitis C Virus Infection

  2015influential citation
• Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.

  2015cites this paper
• The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response

  2015cites this paper
• Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection

  2014cites this paper
• Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma

  2014cites this paper
• Translational Research of Telecare for the Treatment of Hepatitis C

  2014cites this paper
• Management of Chronic Hepatitis C among Asian Americans

  2014cites this paper
• Systematic review: Asian patients with chronic hepatitis C infection

  2013cites this paper
• Hígado y hepatitis C en los adultos mayores: Opciones de tratamiento

  2013cites this paper
• GLOBAL PERSPECTIVES : TAIWAN AND ASIA ( MLYU AND RN CHIEN , SECTION EDITORS ) Molecular Epidemiology of HCV in Asia

  2013influential citation
• Analysis of Extrahepatic Multiple Primary Malignancies in Patients with Hepatocellular Carcinoma according to Viral Infection Status

  2012influential citation
•  The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico.

  2012cites this paper
• Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

  2011cites this paper
• Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels

  2011cites this paper
• Liver Interleukin-8 Messenger RNA Expression and Interferon Sensitivity-Determining Region Mutations Relate to Treatment Response in Hepatitis C 1B

  2011cites this paper
• A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

  2011cites this paper
• Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

  2010cites this paper
• Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan.

  2010cites this paper
• Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas

  2010cites this paper
• Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan

  2010cites this paper
• Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.

  2010cites this paper
• Clinical implications of alpha-fetoprotein in chronic hepatitis C.

  2009cites this paper
• Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.

  2009cites this paper
• Treatment of chronic hepatitis C in Asia: When East meets West

  2009cites this paper
• Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.

  2009cites this paper
• Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan.

  2008cites this paper
• Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor‐κB in chronic hepatitis C

  2008cites this paper
• HIV and hepatitis C coinfection

  2008cites this paper
• Hepatitis C virus genotypes: clinical relevance and therapeutic implications.

  2008cites this paper
• Genetic variation of hepatitis C virus in a cohort of injection heroin users in Wuhan, China.

  2008cites this paper
• Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

  2007cites this paper
• Mutations in the interferon sensitivity‐determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C‐1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

  2007cites this paper
• Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.

  2007cites this paper